4//SEC Filing
Edwards Martin 4
Accession 0001104659-25-074386
CIK 0001657312other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:20 PM ET
Size
18.5 KB
Accession
0001104659-25-074386
Insider Transaction Report
Form 4
Edwards Martin
Director
Transactions
- Sale
Ordinary Shares
2025-08-01$13.14/sh−10,808$142,057→ 157,992 total - Exercise/Conversion
Restricted Stock Units
2025-08-01−24,000→ 72,000 total→ Ordinary Shares (24,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-08-01+24,000→ 168,800 total
Footnotes (6)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The sale reported in the Form 4 represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the Reporting Person's tax withholding obligation upon the vesting of the restricted stock units ("RSUs").
- [F3]The price reported represents the sale price of the ADSs divided by eight (8).
- [F4]Consists of 157,992 Ordinary Shares represented by 19,749 ADSs.
- [F5]Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
- [F6]The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001640073
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 8:20 PM ET
- Size
- 18.5 KB